Halted trial tests new drug for mysterious Multi-Organ disease
NCT ID NCT04918147
Summary
This study tested whether adding the drug elotuzumab to standard steroid treatment (prednisone) could better control IgG4-Related Disease (IgG4-RD), a chronic condition that causes inflammation and scarring in various organs. It involved about 75 adults with active disease affecting at least two organ systems. The trial was designed in two parts: first to check safety, then to compare the drug combination against steroids alone, but it was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGG4 RELATED DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory Healthcare
Atlanta, Georgia, 30322, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic: Pulmonary and Critical Care Medicine
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.